California outlaws pay-for-delay deals

California has become the first US state to ban pay-for-delay deals in the pharmaceutical industry.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More on this story

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More on this story

Americas

California mulls state generics brand

13 January 2020 California’s governor wants the state to establish its own generics brand in a bid to bring down the cost of prescription drugs.

Americas

California pay-for-delay ban upheld during appeal, rules Ninth Circuit

25 February 2020 The US Court of Appeals for the Ninth Circuit has blocked generics makers’ request to halt California’s ban on pay-for-delay deals while they challenge the legislation.

Americas

Par avoids pay-for-delay suit after court accepts payment was ‘fair’

10 March 2020 A Virginia judge has approved Par Pharmaceutical’s settlement with a group of direct purchasers, allowing the pharmaceutical company to escape a pay-for-delay lawsuit.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers

California outlaws pay-for-delay deals

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features